Sharing Models for Cost Effectiveness
What is it about?
A short letter to remind scientists that all the recent discussion on sharing such pharmacoeconomic models is good be we had brought this up 7 years earlier.
Why is it important?
The letter really points out that not through lack of effort its going to take more than people publishing papers on the topic, its going to need some effort and funding.
The following have contributed to this page: Dr Sean Ekins